Pyeazolam (SH-TRI-108) is a triazolobenzodiazepine derivative which has been sold online as a designer drug. It has been found to be relatively selective for the ñ<sub>5</sub> subtype of GABA<sub>A</sub> receptors, in a similar manner to the related compound QH-ii-066, and is claimed to have an effects profile more similar to alcohol than typical benzodiazepines.
Several possible routes for synthesis have been determined.